11
results
for author:"Morgan M.B."
in Literature Citations
| Bif-1 and Bax expression in cutaneous Merkel cell carcinoma. Schlauder S.M., Calder K.B., Khalil F.K., Passmore L., Mathew R.A., Morgan M.B. J. Cutan. Pathol. 36:21-25(2009) · Mapped (8) |
| CD117 immunoreactivity in atypical fibroxanthoma. Mathew R.A., Schlauder S.M., Calder K.B., Morgan M.B. Am J Dermatopathol 30:34-36(2008) · Mapped (6) |
| The DNA sequence, annotation and analysis of human chromosome 3. Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J., Chen R., Cree A., Ding Y. et al. Nature 440:1194-1198(2006) · UniProtKB (2,861) |
| The finished DNA sequence of human chromosome 12. Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A. et al. Nature 440:346-351(2006) · UniProtKB (660) |
| Immunohistochemical expression of Bax and Bcl-2 in penile carcinoma. Saeed S., Keehn C.A., Khalil F.K., Morgan M.B. Ann. Clin. Lab. Sci. 35:91-96(2005) · Mapped (10) |
| Comparative genome sequencing of Drosophila pseudoobscura: chromosomal, gene, and cis-element evolution. Richards S., Liu Y., Bettencourt B.R., Hradecky P., Letovsky S., Nielsen R., Thornton K., Hubisz M.J., Chen R., Meisel R.P. et al. Genome Res. 15:1-18(2005) · UniProtKB (16,003) |
| Hamartin and tuberin immunohistochemical expression in cutaneous fibroepithelial polyps. Wu J., Khalil F.K., Keehn C.A., Saeed S., Morgan M.B. J. Cutan. Pathol. 31:383-387(2004) · Mapped (16) |
| Expression of insulin-like growth factor-I receptor in primary cutaneous carcinomas. Keehn C.A., Saeed S., Bickle K., Khalil F.K., Morgan M.B. J. Cutan. Pathol. 31:368-372(2004) · Mapped (4) |
| Expression of the ets-1 proto-oncogene in melanocytic lesions. Keehn C.A., Smoller B.R., Morgan M.B. Mod. Pathol. 16:772-777(2003) · Mapped (8) |
| Caveolin expression in adult renal tumors. Carrion R., Morgan B.E., Tannenbaum M., Salup R., Morgan M.B. Urol. Oncol. 21:191-196(2003) · Mapped (6) |
| Differential C-erbB-2 and VEGF expression following BCG immunotherapy in superficial papillary transitional cell carcinoma of the bladder. Morgan B.E., Salup R., Morgan M.B. Urol. Oncol. 7:67-72(2002) · Mapped (15) |
